April 2006

For those of you trying to get on two active drugs…. You can get TMC 114 in expanded access. It is taking about 3 weeks to get it if the doctor knows the process. No T cell limit but your doctor has to prove that you have multi drug resistance. Three hours of paper work. […]

Consensus Statement on the Pricing of TMC114 /DarunavirApril 17, 2006 TMC114/darunavir will soon become Tibotec’s first licensed drug for the treatment of HIV disease. It is likely to be the first of several important anti-HIV drugs from Tibotec. To date, the HIV/AIDS community’s relations with Tibotec have been exemplary as the company has shown an

Lipodystrophy, Wasting, Hormones, Exercise, Nutritrion www.medibolics.com Therapies for people failing HIV treatments www.salvagetherapies.org Nelson Vergel’s personal web site www.nelsonvergel.com Subscribe to the largest Internet discussion group by sending a blank email to [email protected] If you are taking Fuzeon or planning to, send a blank email to [email protected] If you have failed most of your HIV

By Nelson Vergel Jon D. Kaiser, M.D., has been a leader in promoting the integration of natural immune system support with state of the art standard medical therapies for HIV. He is also the author of Healing HIV: How to rebuild your immune system (1999 HealthFirst Press). All of Dr. Kaiser’s current treatment guidelines and

I had the pleasure to meet Dr. Walker after his oral presentation on Uridine and mitchondrial toxicity at the Lipodystrophy Conference in Paris. I was very excited to see his in vitro data on how this supplement may protect liver cell mitochondria exposed to D4T (Zerit) and DDC (Hivid). He gladly agreed to be interviewed

I have been seeing many HIV positive men with enlarged parotid glands in my 14 years of travels giving lectures around the country. I was also one of those men with moderate inflammation of the parotid glands. No one really knows what causes this disfiguring inflammation. It could be due to the HIV virus itself,

Face to Face with LipoatrophyAn Interview with David Nolan By Nelson Vergel HIV-related lipoatrophy (fat loss under the skin) is a clinical problem that affects many people living with HIV. Lipoatrophy can cause substantial loss of buttock tissue, veiny legs and arms, and facial wasting. Lipoatrophy can happen alone or in combination with lipohypertrophy (fat

Transcript of The Body’s Live Chat With Nelson Vergel on Issues for HIVers With Multi-Drug Resistance Following is the transcript of The Body’s live chat on issues for HIVers with multi-drug resistance, which took place on Feb. 16, 2005, at 9 p.m. Eastern Standard Time. The chat was sponsored by Roche and Trimeris, moderated by

I wrote this for Test Positive Aware Network’s Positive Aware magazine, one of the best free HIV magazines in the country. Their link is https://www.tpan.com/ Sustiva One of the “preferred drugs” in the DHHS guidelines due to its very good efficacy. It was the first drug to be approved for once-a-day dosing, so everyone jumped

AIDS Activists Cry Foul as Drug Companies Push Prices to Record LevelsPosted Topic Health The following was released by AIDS Treatment Activists Coalition: A steady onslaught of “unreasonable, unacceptable, and unjustified” increases in the price of therapies to treat HIV has caused activists in the US to accuse drugmakers of artificially inflating the market at

Salvage Therapies – New drugs offer hope to patients with multiple-drug resistance HIV virus. By Nelson VergelI have been HIV positive since 1983 and tested in 1986. Like many long- term survivors who started nucleoside monotherapy (AZT, D4T, DDI) in the late ’80s/early ’90s, I have developed multi-drug resistance. Over 40 of my friends have

From Treatment IssuesIt’s Time to Face the Zerit ProblemTreatment Issues: Newsletter of Experimental AIDS Therapies – Volume 17, Number 3, March 2003Nelson VergelWhen I give lectures on how to manage the side effects of HIV medications, I am constantly reminded of how widespread the “sunken cheek” look has become. Many if not most of the